We are live on
!
Find out more
LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Est. Return
10.14%
This Fund
S&P 500
This Quarter
Est. Return
-3.7%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$648M
AUM Growth
-$9.06M
(-1.4%)
Cap. Flow
+$24M
Cap. Flow
% of AUM
3.7%
Top 10 Holdings %
Top 10 Hldgs %
46.83%
Holding
2,692
New
549
Increased
875
Reduced
655
Closed
135
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.72M |
| 2 |
Vanguard Morningstar Growth ETF
VUG
|
+$2.15M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$1.97M |
| 4 |
BXMX
Nuveen S&P 500 Buy-Write Income Fund
BXMX
|
+$1.82M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$1.78M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Preferred and Income Securities ETF
PFF
|
+$2.13M |
| 2 |
Invesco Financial Preferred ETF
PGF
|
+$1.13M |
| 3 |
NIO
NIO
|
+$689K |
| 4 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$524K |
| 5 |
HIX
Western Asset High Income Fund II
HIX
|
+$516K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.19% |
| 2 | Technology | 12.41% |
| 3 | Healthcare | 4.56% |
| 4 | Consumer Discretionary | 4.33% |
| 5 | Industrials | 3.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Lemonade
LMND
$4.1B
| $4K | ﹤0.01% |
+144
| New | +$4.08K |
|
|
LND
1702
BrasilAgro
LND
$359M
| $4K | ﹤0.01% |
+625
| New | +$3.69K |
|
|
LNW
1703
DELISTED
Light & Wonder
LNW
| $4K | ﹤0.01% |
+75
| New | +$4.54K |
|
|
LTC
1704
LTC Properties
LTC
$2.15B
| $4K | ﹤0.01% |
91
+51
| +128% | +$1.8K |
|
1705
Madrigal Pharmaceuticals
MDGL
$11.8B
| $4K | ﹤0.01% |
+39
| New | +$3.29K |
|
1706
MidCap Financial Investment
MFIC
$804M
| $4K | ﹤0.01% |
271
| – | – |
|
1707
Melco Resorts & Entertainment
MLCO
$2.14B
| $4K | ﹤0.01% |
479
-3,147
| -87% | -$30.3K |
|
1708
Morningstar
MORN
$7.53B
| $4K | ﹤0.01% |
16
+9
| +129% | +$2.54K |
|
|
MTLS
1709
Materialise
MTLS
$396M
| $4K | ﹤0.01% |
191
-286
| -60% | -$5.76K |
|
1710
Minerals Technologies
MTX
$2.34B
| $4K | ﹤0.01% |
56
+10
| +22% | +$692 |
|
1711
Neurocrine Biosciences
NBIX
$16.6B
| $4K | ﹤0.01% |
46
-42
| -48% | -$3.56K |
|
1712
Vitamin Cottage Natural Grocers
NGVC
$654M
| $4K | ﹤0.01% |
+188
| New | +$3.12K |
|
|
NOVA
1713
DELISTED
Sunnova Energy
NOVA
| $4K | ﹤0.01% |
+158
| New | +$3.38K |
|
1714
NovoCure
NVCR
$1.91B
| $4K | ﹤0.01% |
51
+41
| +410% | +$3.02K |
|
1715
Orion
OEC
$409M
| $4K | ﹤0.01% |
271
| – | – |
|
1716
Oil States International
OIS
$491M
| $4K | ﹤0.01% |
582
+156
| +37% | +$989 |
|
1717
Omeros
OMER
$959M
| $4K | ﹤0.01% |
+602
| New | +$3.75K |
|
1718
Opko Health
OPK
$1.02B
| $4K | ﹤0.01% |
1,137
+137
| +14% | +$484 |
|
1719
Oxford Industries
OXM
$552M
| $4K | ﹤0.01% |
46
-30
| -39% | -$2.65K |
|
1720
Pacific Biosciences
PACB
$370M
| $4K | ﹤0.01% |
437
+201
| +85% | +$2.31K |
|
1721
Peapack-Gladstone Financial
PGC
$812M
| $4K | ﹤0.01% |
+109
| New | +$4.01K |
|
|
PINC
1722
DELISTED
Premier
PINC
| $4K | ﹤0.01% |
113
+13
| +13% | +$484 |
|
1723
Pentair
PNR
$11B
| $4K | ﹤0.01% |
67
+20
| +43% | +$1.21K |
|
1724
Insulet
PODD
$9.79B
| $4K | ﹤0.01% |
16
-3
| -16% | -$736 |
|
1725
Post Holdings
POST
$3.57B
| $4K | ﹤0.01% |
63
-29
| -32% | -$2.03K |
|
Similar funds
SBIA
CHP
MW
TAM
SIA
CIG
CCM
WCF
Lindbrook Capital's Q1 2022 Portfolio in Review
As of Q1 2022, Lindbrook Capital held 2,692 positions worth $648M, down 1.4% from $657M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Lindbrook Capital deployed $24M of net new capital in Q1 2022, opening 549 new positions and adding to 875 existing holdings. Its largest new stake was Claros Mortgage Trust: 59,524 shares worth $1.02M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was iShares Preferred and Income Securities ETF, an estimated $2.13M trimmed.
- Lindbrook Capital's largest Q1 2022 buy was Claros Mortgage Trust: 59,524 shares worth $1.02M.
- Lindbrook Capital added most to Apple in Q1 2022, an estimated $2.72M increase.
- Lindbrook Capital's biggest Q1 2022 reduction was iShares Preferred and Income Securities ETF, cutting an estimated $2.13M.
- Lindbrook Capital fully exited iShares 1-5 Year Investment Grade Corporate Bond ETF in Q1 2022, selling an estimated $524K.
- Lindbrook Capital's ten largest holdings make up 47% of its $648M portfolio in Q1 2022.
- Lindbrook Capital opened 549 new positions and closed 135 in Q1 2022.
- Lindbrook Capital's portfolio value fell 1.4% quarter-over-quarter to $648M.
Based on Lindbrook Capital's 13F filing for Q1 2022, filed 21 Apr 2022.